Cargando…
PARP Inhibitors: An Innovative Approach to the Treatment of Inflammation and Metabolic Disorders in Sepsis
Sepsis is not only a threat to the health of individual patients but also presents a serious epidemiological problem. Despite intensive research, modern sepsis therapy remains based primarily on antimicrobial treatment and supporting the functions of failing organs. Finding a cure for sepsis represe...
Autores principales: | Wasyluk, Weronika, Zwolak, Agnieszka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110256/ https://www.ncbi.nlm.nih.gov/pubmed/33986609 http://dx.doi.org/10.2147/JIR.S300679 |
Ejemplares similares
-
Metabolic Alterations in Sepsis
por: Wasyluk, Weronika, et al.
Publicado: (2021) -
Sepsis as a Pan-Endocrine Illness—Endocrine Disorders in Septic Patients
por: Wasyluk, Weronika, et al.
Publicado: (2021) -
Heart Metabolism in Sepsis-Induced Cardiomyopathy—Unusual Metabolic Dysfunction of the Heart
por: Wasyluk, Weronika, et al.
Publicado: (2021) -
Methodological Aspects of Indirect Calorimetry in Patients with Sepsis—Possibilities and Limitations
por: Wasyluk, Weronika, et al.
Publicado: (2022) -
An update on PARP inhibitors for the treatment of cancer
por: Benafif, Sarah, et al.
Publicado: (2015)